Glucagon-like peptide-1 (GLP-1) compounds have emerged as a compelling therapeutic strategy for managing metabolic disorders. These naturally occurring substances are secreted by the gut in response to food intake, stimulating insulin production and suppressing glucagon release. GLP-1 agents demonstrate promising therapeutic efficacy in treating ty… Read More